AM
Anthony J Maddaluna
Director

Anthony J Maddaluna insider trades: Intec Pharma (NTEC) stock buys and sales

Director, Intec Pharma Last trade Aug 27, 2019 125 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2013
4
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Anthony reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 27, 2019NTEC↑ Buy$12K
Dec 2, 2016AMRI↑ Buy$25K
Nov 9, 2016PFE↓ Sell$330K
May 9, 2016PFE↓ Sell$302K
Feb 12, 2015PFE↓ Sell$314K
Feb 10, 2015PFE↓ Sell$304K
Dec 8, 2014PFE↓ Sell$208K
Oct 29, 2014PFE↓ Sell$72K
Nov 14, 2013PFE↓ Sell$3.0M
Nov 1, 2013PFE↓ Sell$1.3M
Mar 8, 2013PFE↓ Sell$535K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Anthony J Maddaluna's insider trades

Anthony J Maddaluna is a director at Intec Pharma (NTEC). Since Mar 8, 2013, Anthony has reported 2 open-market purchases worth $37K and 9 sales worth $6.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (106 filings), shares withheld for taxes (11 filings), option exercises (8 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NTEC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.